For the quarter ending 2025-09-30, HIT had -$114,553 decrease in cash & cash equivalents over the period.
| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net income | 452,176 | 1,129,223 |
| Write-off of accounts receivable | -4,089 | 5,990 |
| Amortization of debt discount | - | 0 |
| Amortization expense | 217,981 | 271,966 |
| Provision for refund liability | 1,413,345 | 955,743 |
| Deferred tax benefits | 12,680 | -66,547 |
| Interest income | 16,003 | 31,998 |
| Stock-based compensation expense | 292,552 | 1,201,134 |
| Accounts receivable | -416,592 | -359,982 |
| Other receivables | 16,272 | 3,354,582 |
| Prepaid expenses and other current assets | 486,424 | 204,241 |
| Long-term prepaid expenses | -151,000 | 357,666 |
| Operating lease right-of-use assets and liabilities, net | -18 | -37 |
| Accounts payable and accrued expenses | -224,639 | 2,269,897 |
| Income taxes payable | -34,944 | -170,309 |
| Other current liabilities | -1,500,000 | - |
| Net cash provided by operating activities | 673,973 | 2,008,629 |
| Development of software | 744,841 | 1,613,372 |
| Net cash used in investing activities | -744,841 | -1,613,372 |
| Payments of deferred offering costs | 43,685 | 106,339 |
| Net cash used in financing activities | -43,685 | -106,339 |
| Increase (decrease) in cash and cash equivalents | -114,553 | 288,918 |
| Cash and cash equivalents at beginning of period | 7,849,248 | - |
| Cash and cash equivalents at end of period | 8,023,613 | - |
Health In Tech, Inc. (HIT)
Health In Tech, Inc. (HIT)